TC
Certified Medical Assistant
Get the full picture
Sign in to uncover key details.
Aegis Laboratory Services
Business Services · United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.aegisls.comRevenue
<$5 MillionIndustry
About Aegis Laboratory Services
Aegis Laboratory Services specializes in certification and testing services for regulated facilities, focusing on safety and quality. Their offerings include consultations, project management, commissioning, and validation services. They cater to a diverse clientele, ranging from local hospital pharmacies and universities to Fortune 500 pharmaceutical manufacturers. Aegis is accredited for USP 797 RCCP-SCF certification and NSF 49 certification for biological safety cabinets.Explore more
Aegis Laboratory Services Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Aegis Laboratory Services
Compare insights from companies similar to Aegis Laboratory Services, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Aegis Laboratory Services Tech Stack
A closer look at the technologies used by Aegis Laboratory Services
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aegis Laboratory Services
Sign Up For FreeTo access detailed company insights
Aegis Laboratory Services specializes in certification and testing services for regulated facilities, focusing on safety and quality. Their offerings include consultations, project management, commissioning, and validation services. They cater to a diverse clientele, ranging from local hospital pharmacies and universities to Fortune 500 pharmaceuti... Read More
